What is the Nippon Shinyaku Co., Ltd. stock price forecast?

Nippon Shinyaku Co., Ltd. is currently trading at ¥3,997. View real-time AI analysis on Alpha Lenz.

What is Nippon Shinyaku Co., Ltd. insider trading activity?

View the latest insider trading data for Nippon Shinyaku Co., Ltd. on Alpha Lenz.

What is Nippon Shinyaku Co., Ltd.'s P/E ratio?

Nippon Shinyaku Co., Ltd.'s P/E ratio is 8.3.

Nippon Shinyaku Co., Ltd.

JPX · 4516

¥3,997+54(+1.37%)Market closed

Ask about Nippon Shinyaku Co., Ltd.'s future dividend policy...

Alpha Chat Insight

“Nippon Shinyaku Co., Ltd. trades at a P/E of 8.3 (undervalued) with solid ROE of 13.9%. Operating margin of 22.1% indicates strong profitability.”

Ask for details →

Company Overview

Nippon Shinyaku Co., Ltd. engages in the research, development, manufacture, and marketing of pharmaceuticals and foodstuffs in Japan and internationally. The company focuses on producing therapeutic drugs for a range of health issues, including hematologic malignancies, urology conditions, and cardiovascular diseases. Moreover, Nippon Shinyaku develops both prescription and over-the-counter medications and is known for its robust research and development programs aimed at creating innovative treatments. Beyond pharmaceuticals, the company operates in the functional food segment, providing products that contribute to health maintenance and improvement. As a key player in the pharmaceutical industry, Nippon Shinyaku Co., Ltd. not only impacts healthcare markets but also contributes significantly to advancements in medical treatments, thereby playing a crucial role in global healthcare improvement.

Websitehttps://www.nippon-shinyaku.co.jp

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

Employees2,243

Company Statistics

FY 2025

Profile

¥269,206,299,733Market Cap

¥160,232,000,000Revenue

0.00Shares Out

2,243Employees

Margins

68.10%Gross

26.40%EBITDA

22.12%Operating

22.55%Pre-Tax

20.32%Net

Valuation

8.27P/E

1.09P/B

1.68EV/Sales

5.13EV/EBITDA

201.96P/FCF

Growth (CAGR)

5.24%Rev 3Yr

6.56%Rev 5Yr

2.47%Op Inc 3Yr

10.34%Op Inc 5Yr

9.21%Net Inc 3Yr

14.03%Net Inc 5Yr

Returns

11.90%ROA

13.94%ROE

13.26%ROIC

Financial Health

¥55,241,000,000Cash & Cash Equivalents

¥-18,943,000,000Net Debt

14.68%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Nippon Shinyaku Co., Ltd. trades at a P/E of 8.3 (undervalued) with solid ROE of 13.9%. Operating margin of 22.1% indicates strong profitability.”

Ask for details →

Frequently Asked Questions

Nippon Shinyaku Co., Ltd. (ticker: 4516) is a company listed on JPX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 2,243 employees. Market cap is $269.2B.

The current price is 3,997 with a P/E ratio of 8.27x and P/B of 1.09x.

ROE is 13.94% and operating margin is 22.12%. Annual revenue is $160.2B.